These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2326880)

  • 1. Cyclosporine bioavailability in heart-lung transplant candidates with cystic fibrosis.
    Cooney GF; Fiel SB; Shaw LM; Cavarocchi NC
    Transplantation; 1990 Apr; 49(4):821-3. PubMed ID: 2326880
    [No Abstract]   [Full Text] [Related]  

  • 2. Sandimmun neoral improves the bioavailability of cyclosporin A and decreases inter-individual variations in patients affected with cystic fibrosis.
    Girault D; Haloun A; Viard L; Bellon G; Gottrand F; Guillemain R; Lenoir G; Ladurie FL; Plouvier E; Storni V
    Transplant Proc; 1995 Aug; 27(4):2488-90. PubMed ID: 7652899
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of cyclosporine A in bilateral lung transplantation candidates with cystic fibrosis.
    Mancel-Grosso V; Bertault-Peres P; Barthelemy A; Chazalette JP; Durand A; Noirclerc M
    Transplant Proc; 1990 Aug; 22(4):1706-7. PubMed ID: 2389438
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic profile and variability of cyclosporine versus neoral in patients with cystic fibrosis after lung transplantation.
    Kesten S; Scavuzzo M; Chaparro C; Szalai JP
    Pharmacotherapy; 1998; 18(4):847-50. PubMed ID: 9692659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered pharmacokinetics of cyclosporin in heart-lung transplant recipients with cystic fibrosis.
    Tan KK; Hue KL; Strickland SE; Trull AK; Smyth RL; Scott JP; Kelman AW; Whiting B; Higenbottam TW; Wallwork J
    Ther Drug Monit; 1990 Nov; 12(6):520-4. PubMed ID: 2274997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diltiazem improves cyclosporine dosage in cystic fibrosis lung transplant recipients.
    Shennib H; Auger JL
    J Heart Lung Transplant; 1994; 13(2):292-6. PubMed ID: 8031814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative bioavailability of cyclosporin from conventional and microemulsion formulations in heart-lung transplant candidates with cystic fibrosis.
    Tan KK; Trull AK; Uttridge JA; Wallwork J
    Eur J Clin Pharmacol; 1995; 48(3-4):285-9. PubMed ID: 7589056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin pharmacokinetics in heart-lung transplant recipients with cystic fibrosis. Effects of pancreatic enzymes and ranitidine.
    Tsang VT; Johnston A; Heritier F; Leaver N; Hodson ME; Yacoub M
    Eur J Clin Pharmacol; 1994; 46(3):261-5. PubMed ID: 8070508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cyclosporine in heart and lung transplant candidates and recipients with cystic fibrosis and Eisenmenger's syndrome.
    Tan KK; Trull AK; Hue KL; Best NG; Wallwork J; Higenbottam TW
    Clin Pharmacol Ther; 1993 May; 53(5):544-54. PubMed ID: 8491066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart lung transplantation for cystic fibrosis.
    Hodson ME
    Acta Univ Carol Med (Praha); 1990; 36(1-4):207-9. PubMed ID: 2130696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heart-lung and lung transplantation in cystic fibrosis].
    Kramer MR; Godfrey S
    Harefuah; 1991 Jul; 121(1-2):34-6. PubMed ID: 1748341
    [No Abstract]   [Full Text] [Related]  

  • 14. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric heart-lung transplantation for cystic fibrosis.
    Maynard LC
    Heart Lung; 1994; 23(4):279-84. PubMed ID: 7960853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast track recovery following en bloc heart-lung-liver transplantation in a patient with cystic fibrosis complicated by severe portal hypertension.
    Konstantinov IE; McNeil K; Yeung S; Fawcett J; Mullany D; Dunning J
    Heart Lung Circ; 2008 Apr; 17(2):154-6. PubMed ID: 17379574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: comparison between cystic fibrosis and other conditions.
    Knoop C; Vervier I; Thiry P; De Backer M; Kovarik JM; Rousseau A; Marquet P; Estenne M
    Transplantation; 2003 Aug; 76(4):683-8. PubMed ID: 12973109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation.
    Krenn K; Klepetko W; Taghavi S; Paulus P; Aharinejad S
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):35-41. PubMed ID: 17481912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart transplant (HT) and heart lung transplant (HLT) in cystic fibroses (CF) patients (an overview).
    Kulczycki LL
    Mater Med Pol; 1990; 22(3):153-5. PubMed ID: 2132420
    [No Abstract]   [Full Text] [Related]  

  • 20. Cystic fibrosis treated with heart-lung transplantation: North American results.
    Frist WH; Fox MD; Campbell PW; Fiel SB; Loyd JE; Merrill WH
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1205-6. PubMed ID: 1989187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.